Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombocytopenia × lusutrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 1

Interventions

eltrombopag 14 romiplostim 7 avatrombopag 6 Platelet Transfusion 6 Cytarabine 6 Radiotherapy 4 Filgrastim 4 Etoposide 4 Carboplatin 4 oprelvekin 3 Peripheral Blood Stem Cell Transplantation 3 Daunorubicin 3 Cyclophosphamide 3 Busulfan 3 hetrombopag 2 fludarabine phosphate 2 Thrombopoietin 2 Lenalidomide 2 Interleukin-11 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Doxorubicin 2 Cyclosporine 2 Amplified Fragment Length Polymorphism Analysis 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 sodium thiosulfate 1 siltuximab 1 sargramostim 1 raltitrexed 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389621 2018-10-30

L-PLUS 2

Shionogi Inc.

Phase 3 Completed

215 enrolled 24 charts 1 FDA

Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡